Since Apex Healthcare Consulting was founded, we have worked with biotech & pharmaceutical companies in various stages of growth including start-ups. The projects have evolved across a range of sectors including novel biologics, cell therapy, small molecule platforms, devices, companion diagnostics to include sectors such as aesthetics and allergy.
The backgrounds of the team include, business development, basic research, clinical research, market research, business analysis and market access such that all our work is evidence or data-led based on rigorous primary and secondary research to ensure full transparency of outputs.
The AHC team offers combination of expertise and experience, and is motivated by problem solving.
David is the MD and founder of Apex Healthcare Consulting. After completing his PhD at Southampton and carrying out post-doctoral research at NorthWestern University, Chicago, he joined the industry first in clinical research and later in project management at Glaxo Laboratories.
Upon completing an MBA in 1993, David joined the International Business Analysis team in Glaxo Holdings, where he spent five years carrying out a variety of strategic projects. In this role he was responsible for commercial analysis and evaluation for a number of international therapy teams most notably working on Zantac for over five years.
After leaving GlaxoWellcome in 1996 David established Praxis Research and Consulting with two colleagues, as one of the founding directors. The company focused mainly on market research and in 1998 spun off the consultancy arm so forming an independent group – Apex Healthcare Consulting.
David Cotterell MD & Founder
Rebecca is a Project Director at Apex Healthcare Consulting. After achieving a first-class Masters degree in Chemistry with French from the University of Exeter, Rebecca joined the pharmaceutical industry as a pharmacy sales representative for Reckitt Benckiser.
Rebecca joined Apex Healthcare Consulting initially as a research analyst and later on as Market Research Manager where she was responsible for managing market research projects across a wide range of therapy areas. In this role, she completed qualifications in both Market Research and Marketing.
In 2008, she joined Allergan as a Senior Analyst responsible for business analysis and market sizing for the EMEA aesthetic portfolio. Latterly, she was the EMEA Market Research Manager for BOTOX in therapeutic indications, managing all launch forecasts, business analysis and market research in the EMEA region.
From 2018, Rebecca returned to Apex Healthcare Consulting as Project Director overseeing a variety of projects across a broad range of therapy areas combining her experience in primary research and forecasting.
Rebecca Roberts Project Director
Diane is a Senior Director at Apex Healthcare Consulting. After completing a BSc at Queen’s University Belfast, Diane joined the pharmaceutical industry in 1987 as a protein biochemist in drug discovery at SmithKline Beecham, leading research projects as principal scientist, across several different therapy areas.
Diane joined the drug development company, Vanguard Medica (now Vernalis) in 1997 initially as Project Director, responsible for the scientific evaluation of in-licensing opportunities; and from 2000 onwards as Director of Business Development managing the technical and commercial aspects of licensing and BD activities in EU, USA and Japan.
From 2003, Diane has been a Senior Director at Apex Healthcare Consulting, working on a variety of projects including product and technology assessment and valuations, commercial due diligence, investment analysis and business development projects
Diane Dourish Senior Director